scholarly journals The moderating role of avoidance behavior on anxiety over time: Is there a difference between social anxiety disorder and specific phobia?

PLoS ONE ◽  
2017 ◽  
Vol 12 (7) ◽  
pp. e0180298 ◽  
Author(s):  
Myriam Rudaz ◽  
Thomas Ledermann ◽  
Jürgen Margraf ◽  
Eni S. Becker ◽  
Michelle G. Craske
Author(s):  
Esmail Soltani ◽  
◽  
Seyed Abdolmajid Bahrainian ◽  
Ali Farhoudian ◽  
Abbas Masjedi Arani ◽  
...  

Objectives: The purpose of the current study was to examine the effectiveness of ACT on symptom severity, fear about negative evaluation, quality of life and mediation role of acceptance, cognitive fusion and value among patients with Social Anxiety Disorder (SAD). Methods: Thirty patients diagnosed with SAD were randomized in the intervention (n=15) or waiting list groups (n=15). The Social Phobia and Anxiety Inventory (SPAI), Brief Fear of Negative Evaluation Scale (BFNE), WHO Quality of Life (WHOQOL), Social Anxiety - Acceptance and Action Questionnaire (SA-AAQ), Cognitive Fusion Questionnaire (CFQ) and Valued Living Questionnaire (VLQ) were administered before, immediately after, and at one month follow up. Repeated measurement design was used in the intervention group to investigate the changes of mediation and outcomes variables in the pretest, during, and post- therapy. Twenty-four patients completed the study. One-way analysis of covariance, Multivariate analysis of covariance and repeated measures was used for analysis. Results: Results showed that there were differences between the intervention and waiting list groups on the severity of symptoms (p=0.001), fear of negative evaluation (p=0.002), and quality of life (p=0.03), as well as in terms of specific measures of SA-AAQ(p=0.001), cognitive fusion (p=0.001), and important section of VLQ(p=0.001). Repeated measurement result showed that acceptance and action of social anxiety and cognitive fusion had a mediating role in the severity of anxiety, fear about negative evaluation, and quality of life. Discussion: Results of the study indicate the effectiveness of ACT for SAD and highlighted mediator contribution acceptance and action and cognitive fusion in severity of social anxiety.


EXPLORE ◽  
2020 ◽  
Author(s):  
Dr Jitender Jakhar ◽  
Mr Anantha Krishna ◽  
Dr Hemant Bhargav ◽  
Dr Shivarama Varambally

Author(s):  
Ryan J. Kimmel ◽  
Peter P. Roy-Byrne ◽  
Deborah S. Cowley

Selective serotonin reuptake inhibitors (SSRIs) are the first-line pharmacological treatment for panic disorder based on their low rate of side effects, lack of dietary restrictions, and absence of tolerance. SSRIs and venlafaxine are attractive first-line treatments for social anxiety disorder. Pharmacological treatments of choice for generalized anxiety disorder are buspirone and antidepressants, including SSRIs and venlafaxine. Benzodiazepines, although effective for all these disorders, lack efficacy for comorbid depression and carry the risk of physiological dependence and withdrawal symptoms. Their greatest utility seems to be as an initial or adjunctive medication for patients with disabling symptoms requiring rapid relief and for those unable to tolerate other medications. Chronic treatment with benzodiazepines is generally safe and effective but should probably be reserved for patients nonresponsive or intolerant to other agents. Larger trials are necessary to determine whether pharmacological agents might be useful as monotherapies, or adjuncts to exposure psychotherapy, for specific phobia.


2015 ◽  
Vol 34 (1) ◽  
pp. 1-27 ◽  
Author(s):  
Gentiana Sadikaj ◽  
D. S. Moskowitz ◽  
Jennifer J. Russell ◽  
David C. Zuroff

2017 ◽  
Vol 52 ◽  
pp. 79-87 ◽  
Author(s):  
Jonah N. Cohen ◽  
Deborah A.G. Drabick ◽  
Carlos Blanco ◽  
Franklin R. Schneier ◽  
Michael R. Liebowitz ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document